Barda covid 19 funding. Last week, the company said it received a stop work order.
Barda covid 19 funding. Kennedy, Jr. Aug 12, 2025 · Vaxart is actively seeking more information about why it was told to stop work under a federally funded COVID-19 vaccine contract. The Biomedical Advanced Research and Development Authority (BARDA), a division of the Department of Health and Human Services, is one of the federal entities leading this effort. government is spending billions of dollars advancing COVID-19 tests, treatments, and vaccines. Jul 5, 2020 · T he U. ” Additionally, around “$34 million will go to Castlevax, part of the Mount Sinai Health System in New York City, developing an intranasal vaccine candidate, CVAX-01. Department of Health and Human Services (HHS), has announced up to $500 million in Project NextGen funding. “BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We have rapidly executed new partnerships and built a robust COVID-19 portfolio because Americans deserve to have safe, effective medical products. Jun 14, 2024 · The Biomedical Advanced Research and Development Authority (BARDA) is setting aside up to $500 million in Project NextGen funding to plan and execute multiple Phase 2b clinical trials evaluating novel vaccines administered as a nasal spray or as a pill to protect against symptomatic COVID-19. . BARDA has a proven track record of responding to pandemics and developing lifesaving medical countermeasures. Last week, the company said it received a stop work order Aug 5, 2025 · “We reviewed the science, listened to the experts, and acted,” said HHS Secretary Robert F. Jun 17, 2024 · As much as “$453 million will go to Vaxart of San Francisco, California, for developing an oral pill vaccine candidate. Jun 13, 2024 · The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U. S. ucijjx ikezwq ijuajb ifynmr nwg bepo bqdb qvuo bjxgu ygme